Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LifeVantage ( (LFVN) ) has issued an announcement.
LifeVantage Corporation announced on April 16, 2026 that longtime executive Steven R. Fife will retire as president, chief executive officer and board member effective April 30, 2026, with director Michael Beindorff stepping in as interim CEO from May 1 through August 4, 2026 under a short-term consulting arrangement. As part of the transition, Fife will provide advisory services through September 11, 2026 and receive continued benefits and partial equity vesting, while board committee roles are being adjusted to maintain governance continuity during the leadership change.
The company has appointed veteran consumer and direct selling executive Terrence O. Moorehead as its new president, CEO and director effective August 5, 2026, signing an at‑will employment agreement that includes an $850,000 base salary, significant cash bonus potential and a mix of time- and performance-based equity tied to revenue and adjusted EBITDA targets. With Moorehead’s track record of brand turnarounds and growth at Nature’s Sunshine and Avon, LifeVantage is signaling an ambition to accelerate growth and strengthen its strategic positioning in the health and wellness sector, while its structured transition plan aims to provide stability for employees, consultants, customers and shareholders during the CEO handover.
The most recent analyst rating on (LFVN) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on LifeVantage stock, see the LFVN Stock Forecast page.
Spark’s Take on LFVN Stock
According to Spark, TipRanks’ AI Analyst, LFVN is a Neutral.
The score is driven primarily by mixed fundamentals: strong margins and a solid balance sheet are offset by deteriorating cash flow and recent revenue contraction. Technicals add pressure due to a clear downtrend, while valuation (low P/E and dividend yield) provides meaningful support. Earnings call takeaways are mixed—supportive guidance and capital returns are outweighed by steep YoY revenue decline, margin pressure, weak cash generation, and leadership transition risk.
To see Spark’s full report on LFVN stock, click here.
More about LifeVantage
LifeVantage Corporation, headquartered in Lehi, Utah and listed on Nasdaq as LFVN, is a health and wellness company focused on nutrigenomics, developing science-backed products that activate cellular-level health processes. Its portfolio includes Protandim activators, TrueScience collagen and skincare, GLP‑1 and gut health systems, nootropic energy drinks, and pet supplements, sold primarily through a network of independent consultants targeting consumers seeking personalized wellness solutions.
Founded in 2003, LifeVantage positions itself as “the Activation company,” aiming to leverage nutrition and naturally occurring compounds to influence gene expression and support overall health. The company’s direct selling model and international expansion underpin its market strategy, combining a differentiated product pipeline with an entrepreneurial consultant community to drive growth across global wellness markets.
Average Trading Volume: 184,302
Technical Sentiment Signal: Sell
Current Market Cap: $55.7M
See more data about LFVN stock on TipRanks’ Stock Analysis page.